ConductScience.org, home

Trial · NCT01342549

Treatment Strategy for Alcohol Use Disorders in Veterans With TBI

NCT01342549, Phase 3, Completed, VA Office of Research and Development; results first posted 2016-06-09

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Treatment Strategy for Alcohol Use Disorders in Veterans With TBI. Trials, record NCT01342549. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01342549

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Treatment Strategy for Alcohol Use Disorders in Veterans With TBI
NCT number
NCT01342549
Status
Completed
Phases
Phase 3
Enrollment
62 participants, actual
Lead sponsor
VA Office of Research and Development
Conditions
Alcohol Dependence
Interventions
Valproate, Naltrexone
First posted
2011-04-27
Last updated
2016-06-09
Results first posted
2016-06-09

Source ClinicalTrials.gov

Registered outcomes1

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
Primary
Time to Relapse to Heavy Drinking as Defined by Having 5 or More Drinks in a Sitting for Men and Will be Assessed Using the Time Line Follow Back for Recent Drinking Method. A Structured Questionnaire Will Review Alcohol Consumed on the Previous Week.
24 weeks

Outcomes1

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARY
Time to Relapse to Heavy Drinking as Defined by Having 5 or More Drinks in a Sitting for Men and Will be Assessed Using the Time Line Follow Back for Recent Drinking Method. A Structured Questionnaire Will Review Alcohol Consumed on the Previous Week.
24 weeksWeeksMEAN

Results by group2

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Time to Relapse to Heavy Drinking as Defined by Having 5 or More Drinks in a Sitting for Men and Will be Assessed Using the Time Line Follow Back for Recent Drinking Method. A Structured Questionnaire Will Review Alcohol Consumed on the Previous Week.
Arm 18.78Standard Deviation 0.97Weeks
Time to Relapse to Heavy Drinking as Defined by Having 5 or More Drinks in a Sitting for Men and Will be Assessed Using the Time Line Follow Back for Recent Drinking Method. A Structured Questionnaire Will Review Alcohol Consumed on the Previous Week.
Arm 215.99Standard Deviation 1.36Weeks

Participant flow6

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDArm 131
Overall StudySTARTEDArm 231
Overall StudyCOMPLETEDArm 131
Overall StudyCOMPLETEDArm 231
Overall StudyNOT COMPLETEDArm 10
Overall StudyNOT COMPLETEDArm 20

Adverse events10

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
otherDrowsinessNervous system disordersArm 11231
otherDrowsinessNervous system disordersArm 21031
otherNauseaGastrointestinal disordersArm 1331
otherNauseaGastrointestinal disordersArm 2931
otherDiarrheaGastrointestinal disordersArm 11031
otherDiarrheaGastrointestinal disordersArm 2931
otherSweatingSkin and subcutaneous tissue disordersArm 1531
otherSweatingSkin and subcutaneous tissue disordersArm 21031
otherAbdominal PainGastrointestinal disordersArm 1331
otherAbdominal PainGastrointestinal disordersArm 2531

Adverse event totals6

The totals the trial posted for each group.

TotalGroupAffectedAt risk
Total, all-cause mortalityArm 1
Total, all-cause mortalityArm 2
Total, other adverse eventsArm 11231
Total, other adverse eventsArm 21031
Total, serious adverse eventsArm 1031
Total, serious adverse eventsArm 2031

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons1

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

Comparison
Arm 1 vs Arm 2: serious adverse events

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT01342549

GET https://conductscience.org/api/trials/v1/NCT01342549/registered